Fig. 1.

Comparison of CCM parameters in all patients (n = 100), typical (n = 53) and atypical CIDP (n = 47), DADS (n = 28) and MADSAM (n = 15) with HC (n = 31). Values are displayed as mean ± SD. Comparison was performed using Kruskal Wallis test with Bonferonni correction. A: Significant reduction of CNFL in all patients (14.6 ± 3.6; p < 0.001), typical (14.6 ± 3.2; p = 0.002) and atypical CIDP (14.5 ± 4.1; p = 0.006), and DADS (13.6 ± 4.1; p = 0.004). HC = 18.6 ± 6.9. B: Significant reduction of CNFD in all patients (24.4 ± 7; p < 0.001), typical (25.4 ± 6.6; p = 0.028) and atypical CIDP (23.2 ± 7.1; p = 0.001), and DADS (22.3 ± 7.7; p = 0.002). HC = 29.5 ± 4.9. C: Significant reduction of CNBD in all patients (30.7 ± 17.5; p < 0.001), typical CIDP (30.1 ± 17.4; p = 0.003), atypical CIDP (31.3 ± 17.7; p = 0.011), and DADS (27.6 ± 17.4; p = 0.005). HC = 42.7 ± 18.8. No significant differences between typical and atypical CIDP